Kelan Thomas

Touro University California — United States

Psychology · Social Sciences

14h-index2.5kcitations33works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psychedelics and Drug Studies(8), Forensic Toxicology and Drug Analysis(5), Schizophrenia research and treatment(4), Neurotransmitter Receptor Influence on Behavior(4), Pharmaceutical Practices and Patient Outcomes(4)

Publications33 total

Concomitant use of antidepressants and classic psychedelics: A scoping review
Journal of Psychopharmacology·2025· 3 citedOpen Access
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
Psychopharmacology Bulletin·2025
Toxicology and Pharmacological Interactions of Classic Psychedelics
Current topics in behavioral neurosciences·2024· 2 cited
Pharmacists and psychedelic medicine
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY·2023· 1 cited
Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics
Journal of Psychoactive Drugs·2023· 3 cited
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
Psychopharmacology·2022· 79 citedOpen Access
Serotonin toxicity of serotonergic psychedelics
Psychopharmacology·2021· 130 cited
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
Scientific Reports·2021· 29 citedOpen Access
Concomitant Calcium Channel Blocker and Antipsychotic Therapy in Patients with Schizophrenia: Efficacy Analysis of the CATIE-Sz Phase 1 Data
Annals of Clinical Psychiatry·2018
Surveys of substance use disorders education in US pharmacy programs
Mental Health Clinician·2018· 29 citedOpen Access
Concomitant Calcium Channel Blocker and Antipsychotic Therapy in Patients with Schizophrenia: Efficacy Analysis of the Catie-Sz Phase 1 Data
Annals of Clinical Psychiatry·2017· 7 cited
Curriculum in Psychiatry and Neurology for Pharmacy Programs
American Journal of Pharmaceutical Education·2017· 30 citedOpen Access
Substance use Education in US Schools of Pharmacy: A Systematic Review of the Literature
Substance Abuse·2017· 24 cited
Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders
Journal of Psychoactive Drugs·2017· 75 cited
Lithium
Side effects of drugs annual·2017
Driving performance comparing older versus younger drivers
Traffic Injury Prevention·2016· 103 cited
Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance
Accident Analysis & Prevention·2016· 16 cited
Valproic Acid-Induced Hyperammonemia and Minimal Hepatic Encephalopathy Prevalence among Psychiatric Inpatients
Annals of Clinical Psychiatry·2016· 5 cited
Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
Pharmacology & Therapeutics·2016· 136 citedOpen Access
A 2015 Survey of Pharmacy Curriculum in Psychiatry and Neurology in the United States
Touro Scholar (Touro College)·2016· 2 cited
page 1 of 2Next →

Frequent Co-authors

Shadi Doroudgar(5), Paul J. Perry(4), Vicki L. Ellingrod(4), Michael J. Keiser(3), Benjamin Malcolm(3), Julie A. Dopheide(3), Jolene R. Bostwick(3), Lisa W. Goldstone(3), Jacquelyn Bainbridge(3), Jeffrey R. Bishop(3), Hannah Mae Chuang(2), Kimberly Bohnert(2), Joanne Canedo(2), Kelly N. Gable(2), Marshall E. Cates(2), Joshua Caballero(2), Tawny Smith(2), Andrew J. Muzyk(2), Ingrid Lopes(2), Priscilla Van Dyke(2)